Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2000
11/15/2000EP1051414A1 Substituted heteroarylmethyl compounds used as herbicides
11/15/2000EP1051413A1 Quinoline derivatives as antibacterials
11/15/2000EP1051407A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
11/15/2000EP1051399A1 Phenylalanine derivatives useful as pharmaceutical agents
11/15/2000EP1051397A1 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/15/2000EP1051374A1 The use of compressed carbon dioxide in chemical reactions
11/15/2000EP1051176A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/15/2000EP0827497B1 Substituted aminophenyluracils as herbicides and insecticides
11/15/2000CN1273584A Imidazolyl-cyclic acetals
11/15/2000CN1273529A Vitronection receptor antagonist
11/15/2000CN1273241A Hydroxy substituted N-alkoxy hindered amine
11/15/2000CN1058495C Polycyclic systems compound and derivatives thereof as neurotransmitter release enhancers useful in the treatment of cognitive disordes and medicine containing them and its use
11/15/2000CN1058490C Tetrazolinone derivatives
11/14/2000US6147253 N-protected/N-substituted-beta-amino-hydroxy sulfonates
11/14/2000US6147216 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/14/2000US6147105 Use in the treatment of estrogen-related diseases
11/14/2000US6147103 Extremely low residual solvent content
11/14/2000US6147097 Imidazole derivatives as anti-HIV agents
11/14/2000US6147090 Cholesteryl ester transfer protein inhibitors used to treat diseases which are exacerbated by low levels of hdl cholesterol and/or high levels of ldl-cholesterol and triglycerides, such as atherosclerosis and cardiovascular
11/14/2000US6147088 Antagonists of gonadotropin releasing hormone
11/14/2000US6147083 Novel substituted 1,2-ethanediamine derivatives which antagonize the pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins, useful for the treatment of asthma, etc.
11/14/2000US6147080 Inhibitors of p38
11/14/2000US6147078 Pyrazinone thrombin inhibitors
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066579A1 Processes for the preparation of piperidylmethylpyridine derivatives
11/09/2000WO2000066578A1 Compounds for the treatment of obesity
11/09/2000WO2000066567A1 Pyrimidinone compounds
11/09/2000WO2000066566A1 Pyrimidine compounds
11/09/2000WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands
11/09/2000WO2000066562A1 Pyrazoles having antiinflammatory activity
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066551A1 Cyclic amide compounds, process for the preparation of the same and uses thereof
11/09/2000WO2000066120A1 Novel catechols as antimicrobial agents
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000039087A3 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000035906A3 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
11/09/2000WO2000035488A3 Vitronectin receptor antagonist pharmaceuticals
11/09/2000DE19922443A1 Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen Use of dopamine D3 receptor ligands for the preparation of drugs for the treatment of renal dysfunction
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000CA2372595A1 Contraceptive compositions containing indoline derivatives and progestational agents
11/09/2000CA2372079A1 Novel catechols as antimicrobial agents
11/09/2000CA2371671A1 Pyrimidinone compounds
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2371629A1 3,3-substituted indoline derivatives
11/09/2000CA2371618A1 Cyclic amide compounds, their production and use
11/09/2000CA2371604A1 Integrin receptor antagonists
11/08/2000EP1050534A1 2,3-methano-amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1050533A1 A process for the preparation of chiral imidazolinone herbicides
11/08/2000EP1050530A1 1-Aza-2-alkyl-6-aryl-cycloalkanes usefull as memory enhancers
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049689A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
11/08/2000EP1049680A1 Substituted aminoalkylidenamino triazines as herbicides
11/08/2000EP1049677A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
11/08/2000EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049670A1 Azetidinecarboxamide derivatives for treating cns disorders
11/08/2000EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
11/08/2000EP1049537A2 Catalytic compositions and methods for asymmetric allylic alkylation
11/08/2000EP1049472A1 Antagonists of gonadotropin releasing hormone
11/08/2000EP0787000B1 Quinazolinone pharmaceuticals and use thereof
11/08/2000EP0769006B1 Small molecule inhibitors of rotamase enzyme activity
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
11/08/2000EP0588917B1 Isoxazole and isothiazole compounds that enhance cognitive function
11/08/2000CN1272844A Benzo (5,6) cyclohepta (1,2-B) pyridine derivatives as farnesyl protein transferase inhibitors
11/08/2000CN1272842A 2-acylaminopropanamines as tachykinin receptor antagonists
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272496A Preparation method of chiral imidazolidinone weedicide
11/08/2000CN1272493A Novel amino-triazole compound, its preparation method and drug composition containing them
11/08/2000CN1058265C Quinazoline derivatives and its preparing method and compositions containing the same
11/07/2000US6143892 Process for making 5-substituted pyrazoles
11/07/2000US6143771 Benzimidazole derivative drugs
11/07/2000US6143766 Benzopyranone and quinolone inhibitors of ras farnesyl transferase
11/07/2000US6143764 Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same
11/07/2000US6143762 Tetrahydroisoquinoline derivatives and their pharmaceutical use
11/07/2000US6143758 Drugs for anticarcinogenic agents
11/07/2000US6143751 Pyridine derivatives and pharmaceutical compositions containing them
11/07/2000US6143750 Alpha 1a adrenergic receptor antagonists
11/07/2000US6143744 Sulfamide-metalloprotease inhibitors
11/07/2000US6143742 Treatment for necrotizing infections
11/07/2000US6143696 Substituted 4-(3-alkenylbenzoyl)pyrazoles
11/07/2000CA2022747C Carboxylic acid derivatives
11/07/2000CA2022488C 2,3-dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments
11/02/2000WO2000064891A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof
11/02/2000WO2000064888A1 Di-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064887A1 Renin inhibitors
11/02/2000WO2000064886A1 Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
11/02/2000WO2000064885A1 Heteroaryl diazacycloalkanes, their preparation and use
11/02/2000WO2000064884A1 Piperidyl-imidazole derivatives, their preparations and therapeutic uses
11/02/2000WO2000064880A1 Selective npy (y5) antagonists
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000WO2000064877A1 2-aminoquinolinecarboxamides: neurokinin receptor ligands
11/02/2000WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064873A1 Renin inhibitors
11/02/2000WO2000064872A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK)
11/02/2000WO2000039083A3 Pyrazole compounds and uses thereof
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
1 ... 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 ... 1080